AstraZeneca and Daiichi Sankyo have moved swiftly to file for FDA approval of a second indication for their TROP2-directed antibody-drug conjugate datopotamab deruxtecan (Dato-DXd), this time for ...
A biomarker could help identify patients with lung cancer who are most likely to benefit from treatment with AstraZeneca and Daiichi Sankyo's TROP2-directed drug datopotamab deruxtecan (Dato-DXd). The ...
The popular harem action series High School DxD is getting a new spinoff manga series based on the descendant of Miyamoto ...
Ifinatamab deruxtecan targets B7-H3 and is a potential first-in-class antibody-drug conjugate for extensive-stage small cell lung cancer. The FDA's Breakthrough Therapy Designation aims to expedite ...
One of the most iconic classics in the harem genre, High School DxD is what many consider the golden standard of action-comedy ecchi. Despite the series' controversial raunchiness and, at times, ...
When Merck & Co. and Daiichi Sankyo last year received an FDA complete response letter for their HER3-directed antibody-drug conjugate (ADC) patritumab deruxtecan, the companies hoped to address ...
High School DxD culminates with Issei Hyoudou and Rias Gremory solidifying their bond. Issei's growth into a powerful devil earns him recognition alongside Rias, leading to their official engagement.
High School DxD fans are waiting for Season 5. The anime series has a strong following. It blends comedy with supernatural action. Issei Hyoudou's story continues in manga and light novels. These ...